|
FY2024
12 months to Jun 30, 2024
|
FY2023
12 months to Jun 30, 2023
|
FY2022
12 months to Jun 30, 2022
|
|
|---|---|---|---|
| Cash Flows from Operating Activities: | |||
| Net income | |||
| Adjustments to reconcile net income to net cash used in operating activities: | |||
| Income earned on cash and investments held in Trust Account | |||
| Changes in operating assets and liabilities: | |||
| Prepaid expenses and other current assets | |||
| Other assets | |||
| Accounts payable and accrued expenses | |||
| Net cash used in operating activities | |||
| Cash Flows from Investing Activities: | |||
| Cash deposited into Trust Account | |||
| Cash withdrawn from Trust Account in connection with redemption | |||
| Net cash provided by investing activities | |||
| Cash Flows from Financing Activities: | |||
| Proceeds from sale of Units in Public Offering, net of underwriting fee | |||
| Proceeds from sale of Private Placement Warrants | |||
| Proceeds from note payable | |||
| Redemption of ordinary shares | |||
| Proceeds from sponsor for extension loans | |||
| Proceeds from sponsor for working capital note | |||
| Payment of offering costs | |||
| Net cash used in financing activities | |||
| Net change in cash | |||
| Cash at beginning of period | |||
| Cash at end of period | |||
| Supplemental disclosure of non-cash financing activities: | |||
| Current period remeasurement adjustment of ordinary shares to redemption value | |||
| Deferred underwriters’ commission charged to temporary equity in connection with the Public Offering | |||
| Initial remeasurement adjustment of ordinary shares to redemption value | |||
| Remeasurement adjustment of ordinary shares to redemption value |
Loading...
